Merck, Daiichi pull lung cancer filing after FDA pushback deals another blow to $4B deal - Fierce Biotech
Source: Fierce Biotech ·
Merck, Daiichi pull lung cancer filing after FDA pushback deals another blow to $4B deal Fierce BiotechIfinatamab Deruxtecan BLA Voluntarily Withdrawn in Previously Treated Extensive-Stage SCLC OncLiveMerck, Daiichi pull US application for second partnered cancer therapy ReutersMerck, Daiichi scrap FDA application for B7-H3 ADC in lung cancer Endpoints NewsDaiichi Sankyo, MSD withdraw cancer…